Bill Gates, long recognized as one of the world’s foremost proponents of vaccines, raised some eyebrows at a recent talk in Australia when he admitted there are “problems” with current COVID-19 vaccines.
Speaking at Australia’s Lowy Institute as part of a talk entitled “Preparing for Global Challenges: In Conversation with Bill Gates,” the Microsoft founder made the following admission:
“We also need to fix the three problems of [COVID-19] vaccines. The current vaccines are not infection-blocking. They’re not broad, so when new variants come up you lose protection, and they have very short duration, particularly in the people who matter, which are old people.”
Such statements came as a surprise to some in light of Gates’ longstanding support of — and investments in — vaccine manufacturers and organizations promoting global vaccination.
However, they were the latest in a string of developments in recent weeks that have increasingly called the COVID-19 vaccines, in particular, into question.
‘This is a grift’: Gates’ investments in mRNA vaccines reveal ‘conflict of interest’
Several analysts and commentators were critical of Gates — but not due to disagreement with the statements he made in Australia. Instead, they argued that he had previously heavily invested in mRNA vaccines at the same time he encouraged a global COVID-19 vaccination campaign and supported mandatory vaccination.
Speaking Jan. 25 on The Hill TV’s “Rising,” co-hosts Briahna Joy Gray and Robby Soave addressed Gates’ statements. Soave initially agreed at face value with Gates’ criticism of current mRNA vaccines, saying:
“He really nails it on the issues that we’re having: the short duration of protection, not a significant discernible impact on the transmission of cases … not a massive benefit for a lot of otherwise healthy and younger people.”
However, Soave — who on Jan. 19 revealed “Facebook files” indicating the CDC significantly influenced content moderation and censorship on the platform pertaining to COVID-19 vaccines — then pointed out Gates’ prior investments that contributed to the development of mRNA vaccine technology.
Soave said, “Bill Gates was a major proponent of mRNA technology … he was an investor in BioNTech, which developed the mRNA vaccine for Pfizer.” “We were just doing some digging,” continued Soave, “[and] we saw that he sold a lot of those shares at … how much profit was that?”
“10x,” replied Gray.
“He invested $55 million in BioNTech back in 2019 and it’s now worth north of $550 million. He sold some stock … at the end of last year, I believe it was, with the share price over $300, which represented a huge gain for him over when he invested.”
Soave then unleashed critical comments directed at Gates: “Let’s follow that trajectory: [Gates] invests heavily in BioNTech, ‘mRNA vaccines are great, this is the future,’ he talks about the vaccine timeline and how we can develop it faster, ‘we might have to cut some corners on safety’ … All in … sells it … makes a huge amount of money … but now it’s ‘yeah, it’s okay, it could be better, but what we really need is this breath spray.’”
Soave was referring to a statement Gates made during his recent talk in Australia, immediately prior to his remarks regarding the mRNA vaccines, where he said:
“We think we can also have, very early in an epidemic, a thing that you can inhale that will mean that you can’t be infected, a blocker, an inhaled blocker.”
Gray raised the issue of conflicts of interest between individuals such as Gates who hold significant positions with drug and vaccine manufacturers, and the federal government’s spending of large sums of taxpayer money to purchase these products. She said:
“This is a grift. These companies are extracting money, taxpayer money as it were, to pay for medical treatments that are not indicated by medical professionals and are less useful than what we already have.
“At the same time, the Biden administration is opening its doors, revolving doors, to people from these various industries like Jeff Zients, who is the new chief of staff for Joe Biden … who has spent his entire career at the kinds of companies, investing in the kinds of companies, that have been overcharging the government for Medicare and Medicaid payments and exact kinds of overpayments. It is an enormous grift and one that is incredibly common.”